Cell Therapy
Gene Therapy
Raw Materials
Overcoming Raw Material Challenges in Cell and Gene Therapy Manufacturing
21 May 2020
SHARE NOW
Vibrant communities and market intelligence.
A briefing with CellGenix and friends
At Phacilitate Leaders World 2020 in Miami, CellGenix led a breakfast briefing to discuss the challenges the advanced therapies industry is facing when it comes to raw materials.
Chaired by Frank Hecht, the hour-long briefing brought us a stellar panel line-up of:
- Stefano Baila of Anemocyte
- Jon Ellis of Invetech
- Jef Pinxteren from CellAppliedResearch
- Bernd Leistler from CellGenix.
Watch to find out more…
More like this
GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD
Biotherapeutics company GentiBio has announced it is to collaborate with Bristol Myers Squibb to develop its best-in-class engineered regulatory T cell platform for patients with inflammatory bowel disease (IBD).
11 August 2022
Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals
World-leading life science park Stevenage Bioscience Catalyst (SBS’s), located in Europe’s largest cluster of cell and gene therapy companies, has welcomed Inspira Pharmaceuticals into its Lab Hotel.
10 August 2022
Pfizer Acquire Global Blood Therapeutics for $5.4 Billion
Pfizer has announced it is to acquire Global Blood Therapeutics (GBT), entering into a definitive agreement with the biopharmaceutical company to develop and deliver transformative therapies to patients of sickle cell disease (SCD).
9 August 2022
